Abstract
Frailty and sarcopenia are multifactorial geriatric syndromes, very prevalent among the older population and share adverse outcomes, such as increased risk for disability, institutionalization and death. Despite a possible inflammatory pathophysiological pathway, common to both disorders, it has been little explored in the literature, limited to a few common cytokines. Thus, it is importa…